Abstract Ageing changes gut microbiota composition and alters immune system function. Probiotics, prebiotics and synbiotics may improve the health status of elderly individuals by modifying the intestinal environment and the microbiota composition, and by stimulating the immune system. In this work, we studied the effects of synbiotic supplementation on the gut microbiota of healthy elderly volunteers. Fifty-one elders were randomly assigned to consume either a synbiotic dietary supplement or a placebo in addition to their usual diet for a 2-week period. The synbiotic product consisted of the probiotic Lactobacillus acidophilus NCFM and the prebiotic lactitol and was ingested twice a day, with a total daily dose of 10 g lactitol and 2×10
Introduction
The gut microbiota plays an essential role in the regulation and maturation of a normal immune response, and alterations in microbiota have been linked with several diseases. Moreover, among the elderly the gut function is often decreased and also immune system function has declined, leading to increased susceptibility to infections in the gastrointestinal tract (Panda et al. 2009 ). The composition and activity changes in the gut microbiota that occur with ageing contribute to the increased susceptibility to disease among the elderly. Some additional health problems may arise from the common use of medical agents which can be harmful for the gut and the microbiota therein.
The gut microbiota reacts to living environments and keeps changing throughout human life (Hopkins et al. 2001) . Changes in the microbiota associated with ageing are still far from elucidated, but there is abundant evidence suggesting that ageing has an effect on the gut microbiota. Culture dependent methods have generally shown a decrease in bifidobacteria levels in elderly, although this has not always been confirmed by molecular methods (Hopkins et al. 2001) . As a matter of fact, there are observations that healthy seniors with an active lifestyle do not have less bifidobacteria than healthy adults (Bartosch et al. 2004; Mariat et al. 2009; Tiihonen et al. 2008) . It has been suggested that the absolute levels of bifidobacteria might not be affected, but that age-related shifts in the species composition could affect the culturability of the bifidobacteria ). Nevertheless, bifidobacteria levels have been found to be lower in centenarians than in adults (Biagi et al. 2010) . Lactobacilli levels, however, may be higher in seniors than in healthy adults (He et al. 2003; Woodmansey et al. 2004 ). Some studies have suggested association with ageing and reduced levels of the genus Bacteroides (Bartosch et al. 2004; Woodmansey et al. 2004 ). On the other hand, in a recent study, Bacteroides were found to be the dominant bacterial group among the microbiota of the majority of the 161 elderly volunteers, but at the same time the proportion of Bacteroides was found to vary greatly between the individuals (Claesson et al. 2011) . Although the total number of clostridia tend to increase with increasing age, the Clostridium cluster XIVab numbers have been suggested to be lower in elderly individuals than in young adults (Hayashi et al. 2003) . Nevertheless, Claesson et al. (2011) found that the dominant Clostridium cluster IV and XIVab proportions varied greatly between elderly subjects, but did not differ greatly from adults overall. Blautia coccoidesEubacterium rectale group (formerly known as Clostridium coccoides-E. rectale group; Liu et al. 2008 ) levels also tend to be lower in elders than in adults (He et al. 2003) . Interestingly, Mueller et al. (2006) concluded that the differences in the B. coccoides-E. rectale group are country specific, since German elders had higher levels of this microbial group than adults, whereas in Italian subjects the effect was inverse. Furthermore, there have been some indications that Faecalibacterium prausnitzii levels are lower in elderly subjects than in adults (Mueller et al. 2006) . Ageing has also been associated with an increase in the diversity of yet unidentified species . However, no difference in diversity was found between Italian elders and young adults (Biagi et al. 2010) . It was emphasized by the authors that the difference in microbiota became greater with increased age, as centenarians had an altered microbiota when compared to both young adults and 70-year-olds. Nevertheless, alterations in the gut microbiota need not necessarily be caused by ageing itself, but can be affected by declining general health status and increased necessity for medications such as antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) (Dethlefsen et al. 2008; Mäkivuokko et al. 2010b) . Moreover, there are differences in microbiota composition between healthy and hospitalized elderly (Bartosch et al. 2004; Hopkins et al. 2001) , further indicating that living conditions and medication have a strong effect on the microbiota composition.
According to Hartikainen et al. (2005) , up to 70% of the elderly use analgesics; NSAIDs are the most widely used analgesics at a rate of 50%. NSAIDs have an adverse effect on the gastrointestinal environment, potentially causing intestinal stress and injury (Laine 2002) . Recent findings also suggest that there are differences in microbial markers and microbiota composition between elderly NSAID users and non-users (Mäkivuokko et al. 2010b; Tiihonen et al. 2008) .
Here, we report the effects of a synbiotic dietary supplement on the gut microbiota of healthy elderly volunteers with a regular use of NSAIDs. The synbiotic combination used in this study was chosen due to the complementary effects of its components on the gut microbiota. Lactobacillus acidophilus NCFM® is a probiotic with documentation of gastrointestinal survival, immunomodulation and beneficial effects on gastrointestinal microbiota composition (Ouwehand and Lahtinen 2009) . Lactitol selectively stimulates the intestinal microbiota, especially lactobacilli and bifidobacteria (Ballongue et al. 1997; Drakoularakou et al. 2007) , and in vitro studies show that lactitol stimulates the growth of L. acid-ophilus NCFM (Mäkivuokko et al. 2010a) . Moreover, L. acidophilus NCFM adapts to using lactitol as its substrate by altering its protein expression (Majumder et al. 2011) .
The present analysis of microbiota was carried out in the framework of a previously conducted clinical intervention, in which administration of L. acidophilus NCFM and lactitol was shown to have a modest but significant improvement in bowel function as compared to the placebo group, as well as changes in intestinal immune biomarkers such as fecal PGE 2 and spermidine levels and an increasing effect on fecal levels of genus Bifidobacterium and L. acidophilus NCFM ). The aim of the present study was to further characterize the impact of the synbiotic treatment on microbiota composition by means of molecular methods. Changes in the major bacterial groups were monitored using real-time quantitative polymerase chain reaction (qPCR) and groupspecific primers. Global changes within the total fecal microbiota were investigated by a non-selective DNAbased method, percent guanine-plus-cytosine (% G+C) profiling, where the total microbiota DNA is fractionated based on its % G+C content.
Methods
Intervention study set-up Healthy elderly subjects aged 65 years or more with regular use of NSAIDs were recruited from the rural city of Kuopio, Finland. A total of 51 subjects were randomized into two groups consuming either a synbiotic product comprising of a combination of lactitol (Danisco Sweeteners, Redhill, UK) and L. acidophilus NCFM (NCFM, ATCC 700396; Danisco Cultures, Madison, WI, USA), or saccharose as placebo. The test product was administered in two 5-g portions containing 2×10
9 CFU of NCFM per gram of product, one dose in the morning and one dose in the evening. The daily dose was therefore 2×10 10 CFU of NCFM and 10 g of lactitol per volunteer. The intervention was executed as a double blind study with a 2-week run-in period, a 2-week intervention period and a 2-week wash-out period during which consumption of any other probiotics was prohibited. The study subjects, study product and study design have been presented in more detail by .
Quantification of microbial groups by quantitative PCR
The bacterial DNA from fecal samples of the 47 volunteers who completed the study was extracted according to a method described by Apajalahti et al. (1998) and the DNA concentration and purity was estimated by spectrophotometer (NanoDrop ND-1000; NanoDrop Technologies, Inc., Wilmington, DE, USA).
qPCR was used for quantification of the genus Atopobium, the Bacteroides-Prevotella-Porphyromonas (BPP) group, the genus Lactobacillus, the B. coccoides-E. rectale group, the Clostridium cluster XIVab, and F. prausnitzii and related strains, using previously described primers (Table 1 ). For the qPCR reactions, 1 ng of bacterial DNA was amplified in a 25-μl reaction buffer containing 1× SYBR Green PCR Buffer (Applied Biosystems, Foster City, CA, USA) and 300 nM both forward and reverse primers for analysis of BPP and B. coccoides-E. rectale, 250 nM primers for analysis of F. prausnitzii, and 200 nM primers for analysis of Lactobacillus and Atopobium. Clostridium cluster XIVab target DNA was amplified in a Power SYBR Green buffer (Applied Biosystems) with 300 nM primers present. All assays were run on an ABI Prism 7,000 Sequence Detection System apparatus (Applied Biosystems) and a 7,000 System SDS software (version 1.2; Applied Biosystems). All reactions were performed in triplicates. Amplification profile for SYBR Green reactions consisted of a 2-min activation at 50°C, a 10-min activation at 95°C, followed by 40 cycles of 15 s denaturizing at 95°C, 30 s annealing at specific temperatures (see Table 1 ) and 30 s extension at 72°C. The Power SYBR green amplification differed from this profile by having no separate extension period. Absolute quantification was performed by using standard curves based on known quantities of the standard strains (see Table 1 ). The results are expressed as quantity of bacterial cells g −1 feces
(wet weight).
Bacterial community profiling
The extracted DNA from the 47 study subjects was stratified to subject gender, sample DNA concentration and treatment allocation, and pooled into pairs to ensure sufficient quantity of DNA for the analysis.
Total DNA quantity in each sample pair was set to 100, 50 or 20 ng depending on DNA availability. A genomic profile for each pair was created using a cesium chloride (CsCl)-bisbenzimidazole gradient analysis as described by Apajalahti et al. (1998) . The chase liquid perfluorocarbon (Fluorinet FC-40; Isco Inc., Lincoln, NE, USA) was used for disgorgement in a continuous flow, without disturbing the gradient, controlled with a syringe pump (Multi-Phaser BS-8000; Braintree Scientific Inc., Massachusetts, USA) that kept a constant flow of 4.6 ml min −1
. The CsCl gradient was forced consistently into an UV spectrophotometer (UV Monitor model 280; Spectrum Chromatography, Houston, TX, USA) and DNA quantification was based on A 280 . For determination of relative abundance of % G+C content regression analysis was used (Apajalahti et al. 1998 ).
Statistical analysis
Differences within the microbial groups quantified with qPCR over time were calculated using basic ANOVA for raw values and subsequent Student'sttest, as well as using linear mixed-effects model on log-transformed data with fixed effects for individual baseline, time-point, intervention, time-point-intervention joint effect, and a random effect for subject. Contrasts for linear mixed-effects models were determined for those factors with significant p values in ANOVA test. The individual baseline was estimated from the run-in period sample.
The % G+C profiles were analyzed with a novel approach comprising of a sliding window of fixed size moved over the profiles, and then fitting a linear mixed-effects model to the data in the window. The motivation for this approach was the need to objectively avoid the partitioning of the profiles into fixed sized bins, which potentially biases the analyses if some critical part of the profile becomes divided into different bins. The fitted mixed-effects models had fixed effects for percentile, group, time-point, and group-time-point joint effect, and random effect for subject. The window was slid over the whole % G+C curve in steps of one percentile, and the linear mixedeffects model was fitted to each window independently. We used window size five here, after trying both larger and smaller windows and noticing that only extreme window sizes (<3 and >10) radically changed the results. Notably, while the sliding of the window overcomes the need for any fixed bins for profile data and makes the analysis more robust for window size choice, one should keep in mind that the resulting p values are only indicative, since they are necessarily computed from overlapping data (from the sliding windows). Nevertheless, we believe that these kind of new computational approaches are needed for new type of data.
Results
A total of 47 volunteers in the synbiotic group (n=23; mean age 71.7 years, SD 6.2 years) and the placebo group (n=24; mean age 70.3 years, SD 7.2 years) completed the study and provided fecal samples. The % G+C profiling was performed to assess changes in the total microbiota profile within the two test groups over time (Fig. 1a and b for placebo and synbiotic group, respectively) and between treatments at specific time-points (Fig. 2a, b and c) . A sliding window model was used to determine p values for the relative abundances between treatment groups and timepoints. Initial data analysis revealed that the % G+C profiles obtained from samples with 20 ng DNA or less were systematically skewed irrespective of the treatment allocation; therefore, the % G+C profiles obtained from samples with 20 ng DNA or less (both at run-in and intervention time-points, n=4; at washout time-point, n=6) were excluded from the subsequent analyses as statistical outliers.
The statistical significances of the differences, dependent on time-point, group allocation or the combination of both, in the % G+C profiles obtained from all volunteers, from the group receiving placebo and from the group receiving the synbiotic treatment are presented in Fig. 3a, b and c, respectively. Significant changes in the microbial profiles obtained from all elderly volunteers were observed between time-points irrespective of treatment allocation, but also treatment-dependent differences (P<0.05) were detected at specific time-points at % G+C ranges of 23 to 41%, 43 to 51% and 56% and above (Fig. 3a) .
Within these % G+C ranges the relative abundance changed over time within the treatment groups, as can be seen in Fig. 1 . On further inspection of the differences within the treatment groups over time it was observed that within the placebo group there were no significant changes between run-in and intervention time-points (Fig. 3b) , whereas there were various changes in relative abundance in the synbiotic group (Fig. 3c) . The changes in relative abundance during synbiotic treatment were statistically significant in all percentiles except at 41 to 44, and 53 to 62% G+C. During the wash-out period, there were some changes in both treatment groups, with differences between intervention and wash-out at 30-45%, and 51-63% G+C in the placebo group, and at 23-28%, 46-53%, and 60% G+C and above ranges in the synbiotic group, as shown in Fig. 3b and c .
In addition to the % G+C profile analyses, the microbial populations were further assessed by quantitative PCR. The baseline-corrected results of the fecal microbiota quantification by qPCR are presented in Tables 2 and 3 . Initial t-test showed an increase in total Lactobacillus levels in the group receiving the synbiotic, followed by a decrease during wash-out, whereas there were no significant changes in the placebo group. After baseline correction the decrease from intervention to wash-out was still significant in the synbiotic group (P=0.0005). There was no difference in lactobacilli levels between the treatment groups at intervention, possibly because the total quantities were higher in the placebo group than in the synbiotic group at both run-in and wash-out time-points (P=0.0106 after baseline correction). The B. coccoides-E. rectale group and Clostridium cluster XIVab levels declined from run-in to wash-out in both test groups, but in the synbiotic group also the decline from intervention to wash-out was significant (from 1.83×10 10 to 1.34×10 10 cells g −1 and from 1.19× 10 10 to 7.34×10 9 cells g −1 , respectively). The effect persisted also after baseline correction (P=0.0034 and P=0.0001, respectively). The initial t-tests on raw values showed a decrease in Atopobium levels from run-in to wash-out time-points in both test groups, but the baseline corrected tests did not confirm the decrease. To facilitate the interpretation of the results and to give more comprehensive view of the microbial changes associated with the synbiotic intervention, the qPCR results for bifidobacteria, L. acidophilus species, L. acidophilus NCFM, Clostridium perfringes, sulphate reducers and total microbes, reported in a previous report of the study ), are also included in Tables 2 and 3 . Notably, bifidobacteria were elevated in the group receiving synbiotic treatment in comparison to the placebo group, as were the levels of L. acidophilus NCFM.
Discussion
Ageing has a profound effect on several functions in the human body including immune system function and metabolism, both of which are slowed down (Delarosa et al. 2006) . Also, the gastrointestinal tract is affected, resulting in increased transit times and an alteration in intestinal microbiota composition (Claesson et al. 2011; Mäkivuokko et al. 2010b; Mueller et al. 2006; Woodmansey 2007) . Apart from acute bacterial infections, the direct evidence and the proof for causality linking the age-related microbiota and the reduced gastrointestinal and overall health status in the elderly are currently lacking. Nevertheless, there are indications for such a link, as evidenced by the studies demonstrating differences in the microbiota of healthy and hospitalized elders (Bartosch et al. 2004 ) and elders who are or are not taking NSAIDs (Mäkivuokko et al. 2010b ). Moreover, in adults there are many studies linking altered gut microbiota with health problems such as irritable bowel syndrome (Lyra et al. 2009; Maukonen et al. 2006 ) and inflammatory bowel disease (Kassinen et al. 2007; Si et al. 2004 ). These considerations provide rationale for the modulation of gut microbiota of elderly subjects towards a microbiota typical of healthy adults. While microbiota modulation may not be considered a clinical health benefit per se, Fig. 3 P values from a ANOVA F-test and b, c contrast test for the original data in the relative abundance of % G+C profiles associated with a treatment, time-point, and treatment-timepoint for both groups, and difference between separate timepoints in the b placebo and c synbiotic group, analyzed using a sliding window model. Clear significant differences in the % G+C relative abundances are observed irrespective of the treatment allocation and also within the treatment groups at specific time-points. Differences between the run-in and intervention time-points within the synbiotic group reach statistical significance (P<0.05) at 41% and under, 44-53%, and 62% G+C range and above Data from counteracting the age-and disease-related changes in the gut microbiota, e.g., by using probiotics, prebiotics or synbiotics can be considered to be beneficial. Probiotic, prebiotic and synbiotic therapies possess great potential for improving the general health within the elderly population. To fulfill this potential, it is essential to identify probiotic and prebiotic products that have the desired effects.
The aim of the present study was to investigate the changes in microbiota composition induced by a synbiotic product containing the probiotic L. acidophilus NCFM and the prebiotic lactitol in healthy elderly with regular use of NSAIDs. The study was conducted within the framework of a previously reported clinical study ), using DNA extracted from the fecal samples collected during the original study and stored frozen until analysis. Of the 51 recruits, 47 completed the study. By combining a quantitative and a qualitative method, changes in both the overall intestinal microbiota and in some specific microbial groups were recorded over the 6-week intervention. A correction for baseline values was applied on bacterial quantities and all statistical analyses were corrected to minimize the effect of the possible confounding factors unrelated to the intervention.
We assessed the overall microbial profile of the study subjects by % G+C profiling, which is one of few techniques where the whole microbial community can be depicted in a single analysis without bias, and which has been shown to be very reproducible (Apajalahti et al. 2001) . The profiles in Fig. 1 illustrate that the most abundant bacteria represented species with 34 to 48% G+C, with the highest peak at approximately 42% G+C. Although the % G+C profiles did differ between the treatment groups to some extent, the differences were not significant (Fig. 3a) , probably due to the high natural variability of the initial % G+C profiles between the individuals. For a data of such high natural variability among the subjects, the analyses between the time-points within the groups may be more appropriate. Indeed, clear significant differences in the % G+C relative abundances were observed between time-points irrespective of treatment in several ranges. In the synbiotic group there was a shift in relative abundance during the treatment in most percentiles, indicating changes in the overall balance of the bacterial community. Compared to the relative abundances of different % G+C ranges at run-in, the low % G+C range represented a smaller proportion and the high % G+C range represented a higher proportion of the total microbiota following the synbiotic treatment (see Figs. 1 and 3c) . Similar changes were not observed within the placebo group (see Figs. 1 and 3b) . The result demonstrates that the synbiotic treatment does cause changes in the microbial community which are significant enough to alter the overall balance of the microbiota and the relative proportions of the bacterial groups. Nevertheless, the clinical impact of this shift remains unknown as does the identity of the bacterial groups responsible for the observed population shifts-perhaps with the exception of bifidobacteria. The small peak at approximately 60% G+C suggests increased bifidobacteria levels at the end of intervention in the synbiotic group as compared to the run-in time-point (see Fig. 1 ). Interestingly and in accordance with the present % G+C analysis, an increase in the levels of bifidobacteria was also observed by qPCR analysis (see Tables 2 and 3 ) ). While the % G+C and qPCR results both suggest that the synbiotic treatment was associated with an increase in the levels of bifidobac- teria, a member of the phylum Actinobacteria, it should be noted that also other bacterial groups with high % G +C content may have also contributed to the microbial shifts in the high % G+C range. Such groups may include other members of the phylum Actinobacteria such as the genus Collinsella. As typical of % G+C data in general, in the case of the "Bifidobacterium peak" the range of the statistical significance actually started from the shoulder of the peak (from % G+C 62 and above). The probable explanation for this is the fact that the variation of the % G+C data is always highest at the peaks and reduced in the slopes of the curves. The same phenomenon was encountered also at the interval of the highest peak at % G+C 41 to 44-changes were statistically significant on both sides of the peak, but not at its highest point. There were some changes in the % G+C profiles during the wash-out period in both treatment groups caused by an unknown factor, but the changes were more pronounced within the placebo group. A less stable microbiota might have been the cause of this sudden shift. In the low % G+C area (<25%) the difference in relative abundance between run-in and intervention was significant in both treatment groups ( Fig. 3b and c) , possibly indicating some methodological bias at very low % G+C ranges, perhaps induced by data normalization within the range of % G+C 20 to 80. All values depicted in the % G+C profiles are relative, which results in that one shift in the microbiota can affect the whole profile. For example, a large increase in one bacterial group increases the relative abundance of this group, which automatically reduces the relative contribution of the other groups, even if their absolute levels remain stable.
In order to identify which bacterial groups were responsible for the changes observed in the % G+C profiles, a series of qPCR targeting major groups of intestinal bacteria were performed. Quantification of microbial groups by qPCR showed selective changes in the gut microbiota of the NSAID using elders. The total lactobacilli levels increased by 1.22×10 8 cells g −1 feces during synbiotic intervention, and decreased during wash-out period in the synbiotic group, whereas there were no significant changes within the placebo group. Initially during the run-in phase, the subjects in the placebo group had higher levels in total lactobacilli, which resulted in similar levels in both groups at the time of the intervention. The increase in total lactobacilli observed here was higher (increased by 4.08×10
) than the increase in the levels of the administered probiotic L. acidophilus NCFM (Table 2; ), indicating an increase in endogenous lactobacilli. This increase was likely to be induced by lactitol, which has shown to be a good substrate for lactobacilli (Mäkivuokko et al. 2010a ). Elderly NSAID users have an altered microbiota with decreased levels of lactobacilli, as compared to nonusers (Mäkivuokko et al. 2010b) , and therefore the increase in lactobacilli levels in this population can be considered beneficial. The % G+C content of lactobacilli is typically around 35%; in the case of L. acidophilus NCFM, the % G+C content is 34.7% (Altermann et al. 2005) . There are vast amount of other microbes with % G+C content within similar range as lactobacilli. In addition, the qPCR results showed that the administered probiotic and lactobacilli in general form only a minor part of the total microbiota (typically <1%). Therefore, it is not surprising that the changes in the levels of lactobacilli and L. acidophilus NCFM detected by qPCR were not linked with detectable changes in the % G+C profiles.
A decrease in the B. coccoides-E. rectale group has been connected to NSAID use in elders, as compared to healthy adults (Tiihonen et al. 2008) . Both the B. coccoides-E. rectale group and Clostridium cluster XIVab levels declined throughout the 6-week study period in both test groups, possibly indicating some instability in these microbial groups. In the placebo group there was a slight decline in every time-point, whereas the decrease in both these microbial groups seemingly halted during the synbiotic supplementation (no change over time), but after the synbiotic treatment was stopped, a decline from treatment period to wash-out was also observed in these volunteers for both groups (decreases by 4.9×10 9 and 4.6×10 9 cells g −1 , respectively). As both the B. coccoides-E. rectale group and the Clostridium cluster XIVab are fundamental to the microbiota and they contain important producers of butyrate, the major source of energy for colonocytes, there could be health implications arising from instability of this bacterial group (Louis et al. 2007 ). However, during this intervention the fecal butyric acid levels were not changed ). There are several reports of age-related differences in the B. coccoides-E. rectale group but to our knowledge the instability of these bacteria in the elderly has not been observed before. In adults the instability in the B. coccoides-E. rectale group has been associated with irritable bowel syndrome (Maukonen et al. 2006) . As with lactobacilli, the changes in the levels of the B. coccoides-E. rectale group detected by qPCR are not directly apparent in the % G+C profiles, since there are a number of different bacterial groups overlapping each other in the low % G+C range. In a previous report by Claesson et al. (2011) an extensive analysis of the intestinal microbiota of 26 elderly subjects showed that although there is great interindividual variability, most of the test subjects had a stable microbiota over time. Nevertheless, a few subjects did have some variation in their microbiota, but the variation was not associated with nonantibiotic medication or illness. In this work, we observed significant changes in the microbial profiles of the elderly over time, irrespective of the treatment allocation (Table 2 and Fig. 2 ), and these changes may have masked some of the potential effects of the intervention product. The cause of such changes is currently unknown, but they may relate, e.g., to changes in the diet. Also the differences between the test groups at the beginning of intervention might have masked some of the treatment effects. The observed changes unrelated to the intervention suggested instability in some of the bacterial groups, indicating that healthy elderly NSAID users can have an unstable microbiota, as reported earlier by Mäkivuokko et al. (2010b) .
In conclusion, the consumption of the synbiotic combination with L. acidophilus NCFM and lactitol had an effect on the microbiota composition. The microbial community profiling suggested specific changes in the relative abundance during intervention, and using our novel sliding window approach for analyzing the profiles we observed that the relative levels of most G+C percentiles were affected during synbiotic treatment. Nevertheless, the quantification data suggested that the effects on the microbiota were indeed specific. Quantification revealed increased fecal numbers of endogenous lactobacilli and bifidobacteria, and also a possible stabilizing effect on B. coccoides-E. rectale and Clostridium cluster XIVab levels. Our findings further reinforce the effects on microbiota reported previously for this combination ) and suggest that this change is strong enough to cause detectable differences in the overall relative bacterial profiles. Other bacterial groups quantified, including some of the most common commensal microbes of normal gut microbiota, were not affected by the synbiotic treatment, suggesting that the effects of the treatment were specific to certain bacterial groups generally considered to be beneficial for the health. By definition, prebiotics and synbiotics should be specific for socalled beneficial intestinal microbes, but quite often in past studies, the specificity of the prebiotic effect is not properly investigated, and the microbial analyses tend to focus mainly on bifidobacteria and lactobacilli. The main limitation of this work lies with the challenges in combining the results from the two methods used, while the % G+C profiling method yields a good overview of the total microbiota changes, it does not as such allow identification of specific bacterial groups. The qPCR method detects quantitative changes in specific bacterial groups; however, linking these changes with % G+C profiles is challenging particularly in the low % G+C area, where several different bacterial groups overlap each other. The significance of this work stems from the broad range analysis of the effects of the synbiotic treatment on the microbiota as a whole, as assessed by quantifying the major microbial groups by quantitative PCR and by profiling the whole gut microbiota by % G+C profiling.
